RecallRadar

FDA Drug recall D-0228-2018

Divalproex Sodium Delayed Release Tablets USP, 500 mg, 100-count bottle, RX Only, Manufactured by: Unichem Laboratories Ltd

On 2018-01-24 the FDA classified a Class II recall of Divalproex Sodium Delayed Release Tablets USP, 500 mg, 100-count bottle, RX Only, Manufactured by: Unichem Laboratories Ltd by Unichem Pharmaceuticals Usa, citing cross Contamination With Other Products: metronidazole powder was found in one bottle of Divalproex Sodium.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0228-2018
ClassificationClass II
Statusterminated
Initiated2017-12-19
Published2018-01-24
Last updated2026-09-13 11:52 UTC
CompanyUnichem Pharmaceuticals Usa
DistributionUS

Product

Divalproex Sodium Delayed Release Tablets USP, 500 mg, 100-count bottle, RX Only, Manufactured by: Unichem Laboratories Ltd. Ind. Area, Meerut Road, Ghaziabad-201 003, India. Marketed By: Unichem Pharmaceuticals (USA), Inc. Hasbrouck Heights, NJ 07604. NDC 29300-140-01

Reason

Cross Contamination With Other Products: metronidazole powder was found in one bottle of Divalproex Sodium.

Identifiers

ndc29300-138-01
ndc29300-138-05
ndc29300-138-10
ndc29300-139-01
ndc29300-139-05
ndc29300-139-10
ndc29300-140-01
ndc29300-140-05
ndc29300-140-10
code_infoLot: ZDPH17040

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0228-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.